Compare
PRF Technologies Ltd. vs Bioadaptives, Inc. vs Jupiter Neurosciences, Inc. vs Talphera, Inc.
| Latest fiscal year | PRF Technologies Ltd. PRFX | Bioadaptives, Inc. BDPT | Jupiter Neurosciences, Inc. JUNS | Talphera, Inc. TLPH |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $17.0K | $18.3K | $21.8K | $28.0K |
| Revenue growth (YoY) | n/a | +44.3% | n/a | n/a |
| Gross margin | -311.8% (computed) | 68.4% | 80.6% | n/a |
| Operating margin | n/m | n/m | n/m | n/m |
| Net margin | n/m | n/m | n/m | n/m |
| Net income | -$5.02M | -$1.56M | -$8.64M | -$14.29M |
| EPS (Diluted) | -$7.47 | -$0.15 | -$0.25 | n/a |
| Operating cash flow | -$3.96M | -$516.0K | -$5.41M | -$11.36M |
| Free cash flow | -$3.96M | -$534.0K | n/a | n/a |
| Cash & equivalents | $3.12M | $215.2K | n/a | $5.89M |
| Total assets | $12.00M | $225.9K | $5.56M | $29.72M |
| Total liabilities | $2.71M | $2.36M | $7.40M | $12.68M |
| Shareholders' equity | $8.54M | -$2.13M | -$1.83M | $17.04M |
| Return on year-end equity | -58.8% | n/a | n/a | -83.9% |
| Shares outstanding | 830.6K | 12.01M | 34.45M | 49.33M |
Revenue, most recent five fiscal years
| Fiscal year | PRF Technologies Ltd. | Bioadaptives, Inc. | Jupiter Neurosciences, Inc. | Talphera, Inc. |
|---|---|---|---|---|
| Latest | $17.0K Ended 2025-12-31 | $18.3K Ended 2025-12-31 | $21.8K Ended 2025-12-31 | $28.0K Ended 2025-12-31 |
| 1 year earlier | $0 Ended 2024-12-31 | $12.7K Ended 2024-12-31 | $0 Ended 2024-12-31 | $0 Ended 2024-12-31 |
| 2 years earlier | $0 Ended 2023-12-31 | $28.6K Ended 2023-12-31 | n/a | $651.0K Ended 2023-12-31 |
| 3 years earlier | n/a | $17.2K Ended 2022-12-31 | n/a | $0 Ended 2022-12-31 |
| 4 years earlier | n/a | $19.8K Ended 2021-12-31 | n/a | $2.82M Ended 2021-12-31 |